FTC Could Open Arms For Health Claim Science In Regulatory Review
This article was originally published in The Rose Sheet
Executive Summary
FTC is implementing Trump administration directives on "eliminating wasteful, unnecessary regulations and processes," but attempting to reduce regulated industries' compliance burden is not the same as slowing FTC enforcement against false and misleading advertising, attorneys say.
You may also be interested in...
Health, Beauty And Wellness News: Executive Moves
Ohlhausen exits FTC; Morrow heads HempMeds; and Messing recruits for PainTx advisory board.
Sweeping Change At FTC May Sweep Away RCT Standard For Health Claims
Confirmations by the Senate mark FTC ’s first-ever complete leadership turnover at once and fill out the roster for the first time since President Trump’s election in 2016. The agency has been operating with two commissioners since soon after the election.
FTC Chair Nominee Links Ad Claims Enforcement To Consumers' Loss
President Trump nominates as FTC chair Joseph Simons, an antitrust attorney who led its Bureau of Competition under former President Bush. Advertising law attorneys say Simons sees whether consumers incurred economic injury to be central to enforcement on false advertising complaints.